|
Philip Yachmetz was appointed Executive Vice President & Chief Business Officer in February 2006, after joining Savient in May 2004 as Senior Vice President Corporate Strategy, General Counsel and Secretary. Mr. Yachmetz joined us from Progenics Pharmaceuticals, Inc., where he held the position of Vice President, General Counsel and Secretary since 2000. From 1998 to 2000 he served as Senior Vice President, Business Development, General Counsel and Secretary at CytoTherapeutics, Inc. (now StemCells, Inc.). He also founded and served as Managing Director from 1997 to 1998 of Millennium Venture Management, LLC, a business development, consulting and advisory firm to the pharmaceutical, healthcare, and high technology industries. From 1989 to 1996, he held legal positions of increasing responsibility at Hoffmann-La Roche Inc. Mr. Yachmetz is an attorney admitted to the bar in New Jersey and New York.
| 